3rd generation glp 1 agonist Each of GLP-1 is harder to test than the last. Semaglutide has one non-natural amino acid and a C-18 fatty acid at one attachment point. Tirzepatide has two non-natural amino GLP-1 agonists and changes in

It was conducted and reported per the preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 recommendations [15] (see Additional File - Supplementary Material 1)

The company focuses on medical care with behavior change, per the brands site

What cardiovascular monitoring is recommended for patients using GLP-1 medications

M., The New WeightLoss Drugs, Lorcaserin and PhentermineTopiramate: Slim Pickings?, JAMA Internal Medicine 174 (2014): 615619

Smaller Biotechs and Collaborators: Companies like Zealand Pharma, Glycadia, and others have GLP-1 analogs or co-agonists in early trials, often in partnership with larger pharma (e.g., Novo Nordisk collaboration with Zealand)